Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4456382
Max Phase: Preclinical
Molecular Formula: C50H87N3O15
Molecular Weight: 970.25
Molecule Type: Unknown
Associated Items:
ID: ALA4456382
Max Phase: Preclinical
Molecular Formula: C50H87N3O15
Molecular Weight: 970.25
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC(=O)N(C(C)C)C(C[C@H]1C[C@@H](C)C(=O)/C=C/C(C)=C/[C@H](CO[C@H]2O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]2OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]1O)C(=O)NC(C)(C)C
Standard InChI: InChI=1S/C50H87N3O15/c1-17-37-33(25-64-49-46(63-16)45(62-15)42(59)31(9)66-49)21-27(5)19-20-35(54)28(6)22-32(23-34(47(61)51-50(10,11)12)53(26(3)4)38(56)18-2)44(29(7)36(55)24-39(57)67-37)68-48-43(60)40(52(13)14)41(58)30(8)65-48/h19-21,26,28-34,36-37,40-46,48-49,55,58-60H,17-18,22-25H2,1-16H3,(H,51,61)/b20-19+,27-21+/t28-,29+,30-,31+,32-,33-,34?,36-,37-,40+,41-,42+,43-,44-,45+,46+,48+,49+/m1/s1
Standard InChI Key: IYVGRQIWFKWNNG-HKFGJMOTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 970.25 | Molecular Weight (Monoisotopic): 969.6137 | AlogP: 3.29 | #Rotatable Bonds: 15 |
Polar Surface Area: 232.32 | Molecular Species: NEUTRAL | HBA: 16 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.54 | CX Basic pKa: 7.94 | CX LogP: 3.47 | CX LogD: 2.82 |
Aromatic Rings: 0 | Heavy Atoms: 68 | QED Weighted: 0.15 | Np Likeness Score: 1.07 |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):